The chemical class known as PLCXD2 Activators encompasses a range of compounds that can modulate the activity of the enzyme PLCXD2, a phospholipase C variant involved in phospholipid signaling. Activation of PLCXD2, like other members of the phospholipase C family, leads to the hydrolysis of PIP2 into diacylglycerol (DAG) and inositol triphosphate (IP3), secondary messengers vital for the transmission of cellular signals. The activators can influence the PLCXD2 enzyme by either enhancing its catalytic activity or increasing the availability of its substrates within the cellular environment. Some activators operate by affecting the levels of calcium within the cell, which is a crucial cofactor for PLC enzymes, thereby modulating the enzyme's activity. Others interact with signaling pathways upstream of PLCXD2, such as those mediated by G-protein coupled receptors (GPCRs), which can lead to the activation of PLCXD2 as part of a larger signaling cascade.
The varied nature of PLCXD2 activators means that they can come from diverse chemical classes and exert their effects through different mechanisms. For instance, certain activators can bind to regulatory domains of the enzyme, changing its conformation and thus enhancing its catalytic efficiency. Others may alter the lipid composition of cellular membranes, increasing the local concentration of PIP2 and making it more accessible for hydrolysis by PLCXD2. Some compounds can indirectly foster PLCXD2 activity by inhibiting phosphatases that normally act to decrease the levels of PIP2. It's also possible for activators to modulate other signaling molecules that are part of the PLCXD2 signaling pathway, such as PKC, which when activated can further propagate the signal initiated by PLCXD2. Understanding the interplay of these activators with PLCXD2 is essential for a comprehensive grasp of cellular signaling networks and the regulation of phospholipid metabolism.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which enhances the cleavage of PIP2, a substrate for PLC enzymes. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium, modulating PLC activity, including PLCXD2, by altering substrate availability. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Elevates cyclic AMP levels, interacting with signaling pathways involving PLC, potentially affecting PLCXD2. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium levels, similarly affecting PLCXD2 activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits inositol monophosphatase, causing an increase in PIP2 levels, which enhances PLCXD2 activity due to increased substrate availability. | ||||||
ET-18-OCH3 | 77286-66-9 | sc-201021 sc-201021A sc-201021B sc-201021C sc-201021F | 5 mg 25 mg 50 mg 100 mg 1 g | $111.00 $436.00 $843.00 $1576.00 $3756.00 | 6 | |
A synthetic alkyl-lysophospholipid that perturbs lipid signaling pathways, potentially affecting PLCXD2. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
PKC inhibitor that leads to changes in downstream signaling cascades, influencing PLCXD2. | ||||||